# Method Optimization for the Quantification of the NAD

> **NCT05561712** · — · COMPLETED · sponsor: **Société des Produits Nestlé (SPN)** · enrollment: 10 (actual)

## Conditions studied

- NAD

## Interventions

- **OTHER:** Laboratory method validation

## Key facts

- **NCT ID:** NCT05561712
- **Lead sponsor:** Société des Produits Nestlé (SPN)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-25
- **Primary completion:** 2022-03-15
- **Final completion:** 2022-03-15
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05561712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05561712, "Method Optimization for the Quantification of the NAD". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT05561712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*